首页> Cancers> Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.

Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.

导出 OA

翻译打印收藏纠错

第一作者： William,Berry

第一单位： Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC 3168, Australia. waber1@student.monash.edu.;Department of Surgery, Monash University, Clayton, VIC 3800, Australia. waber1@student.monash.edu.

作者： William,Berry ^[1] ; Joanne,Lundy ^[2] ; Daniel,Croagh ^[3] ; Brendan J,Jenkins ^[4]

作者单位： Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC 3168, Australia. waber1@student.monash.edu.;Department of Surgery, Monash University, Clayton, VIC 3800, Australia. waber1@student.monash.edu. ^[1] Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC 3168, Australia. joanne.lundy@monash.edu.;Department of Surgery, Monash University, Clayton, VIC 3800, Australia. joanne.lundy@monash.edu. ^[2] Department of Surgery, Monash University, Clayton, VIC 3800, Australia. daniel.croagh@monash.edu. ^[3] Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC 3168, Australia. Brendan.Jenkins@hudson.org.au. ^[4]

关键词 EUS FNA Pancreatic cancer molecular oncology precision medicine

DOI 10.3390/cancers10020035

PMID 29382047

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交